Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.95
-0.26 (-3.68%)
Aug 1, 2025, 3:48 PM - Market open

Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of $1.23 billion. The enterprise value is $1.60 billion.

Market Cap1.23B
Enterprise Value 1.60B

Important Dates

The last earnings date was Tuesday, July 29, 2025, after market close.

Earnings Date Jul 29, 2025
Ex-Dividend Date n/a

Share Statistics

Teladoc Health has 176.69 million shares outstanding. The number of shares has increased by 3.77% in one year.

Current Share Class 176.69M
Shares Outstanding 176.69M
Shares Change (YoY) +3.77%
Shares Change (QoQ) +1.01%
Owned by Insiders (%) 1.09%
Owned by Institutions (%) 68.14%
Float 164.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.49
Forward PS 0.48
PB Ratio 0.90
P/TBV Ratio n/a
P/FCF Ratio 4.26
P/OCF Ratio 4.10
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 84.66, with an EV/FCF ratio of 5.48.

EV / Earnings n/a
EV / Sales 0.63
EV / EBITDA 84.66
EV / EBIT n/a
EV / FCF 5.48

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.73.

Current Ratio 2.67
Quick Ratio 2.27
Debt / Equity 0.73
Debt / EBITDA 33.35
Debt / FCF 3.55
Interest Coverage -8.07

Financial Efficiency

Return on equity (ROE) is -14.18% and return on invested capital (ROIC) is -4.13%.

Return on Equity (ROE) -14.18%
Return on Assets (ROA) -3.57%
Return on Invested Capital (ROIC) -4.13%
Return on Capital Employed (ROCE) -7.36%
Revenue Per Employee $462,231
Profits Per Employee -$37,701
Employee Count5,500
Asset Turnover 0.79
Inventory Turnover 20.70

Taxes

Income Tax -25.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -25.82% in the last 52 weeks. The beta is 1.85, so Teladoc Health's price volatility has been higher than the market average.

Beta (5Y) 1.85
52-Week Price Change -25.82%
50-Day Moving Average 7.68
200-Day Moving Average 8.90
Relative Strength Index (RSI) 34.00
Average Volume (20 Days) 7,589,518

Short Selling Information

The latest short interest is 24.66 million, so 13.96% of the outstanding shares have been sold short.

Short Interest 24.66M
Short Previous Month 21.57M
Short % of Shares Out 13.96%
Short % of Float 14.97%
Short Ratio (days to cover) 2.74

Income Statement

In the last 12 months, Teladoc Health had revenue of $2.54 billion and -$207.36 million in losses. Loss per share was -$1.19.

Revenue2.54B
Gross Profit 1.79B
Operating Income -183.49M
Pretax Income -997.92M
Net Income -207.36M
EBITDA 18.88M
EBIT -183.49M
Loss Per Share -$1.19
Full Income Statement

Balance Sheet

The company has $679.62 million in cash and $1.04 billion in debt, giving a net cash position of -$355.47 million or -$2.01 per share.

Cash & Cash Equivalents 679.62M
Total Debt 1.04B
Net Cash -355.47M
Net Cash Per Share -$2.01
Equity (Book Value) 1.42B
Book Value Per Share 8.05
Working Capital 671.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $303.43 million and capital expenditures -$11.72 million, giving a free cash flow of $291.71 million.

Operating Cash Flow 303.43M
Capital Expenditures -11.72M
Free Cash Flow 291.71M
FCF Per Share $1.65
Full Cash Flow Statement

Margins

Gross margin is 70.26%, with operating and profit margins of -7.22% and -8.16%.

Gross Margin 70.26%
Operating Margin -7.22%
Pretax Margin -9.14%
Profit Margin -8.16%
EBITDA Margin 0.74%
EBIT Margin -7.22%
FCF Margin 11.47%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.77%
Shareholder Yield -3.77%
Earnings Yield -16.68%
FCF Yield 23.47%
Dividend Details

Analyst Forecast

The average price target for Teladoc Health is $9.67, which is 39.24% higher than the current price. The consensus rating is "Buy".

Price Target $9.67
Price Target Difference 39.24%
Analyst Consensus Buy
Analyst Count 20
Revenue Growth Forecast (5Y) 2.50%
EPS Growth Forecast (5Y) -32.11%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Teladoc Health has an Altman Z-Score of -6.34 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.34
Piotroski F-Score 4